Title: The Serum Hepcidin and the Hepcidin/Ferritin ratio in NAFLD: A Systematic Review
and Meta-Analysis
Version: 3 Date: 06 Dec 2024
Reviewer's report:
The Serum Hepcidin and the Hepcidin/Ferritin ratio in NAFLD: A Systematic Review and Meta-
Analysis
Abstract:
The introduction is long and confusing. Use up-to-date statistics.
Introduction
The gap of knowledge is not well mentioned.
There are many typographical and grammatical errors. The entire text needs to be rewritten. For
example, conducted by the PRISA guideline........ probably means PRISMA.
To structure the eligibility criteria, the PEO...??or PICO
Methods:
I expect the discussion to begin with the key findings of the study.
It is necessary to provide a publication bias funnel plot.
The authors justify the difference between their study and that of Sharma R, Zhao W, Zafar
Y, Murali AR, Brown KE. Serum hepcidin levels in chronic liver disease: a systematic
review and meta-analysis. Clinical Chemistry and Laboratory Medicine (CCLM). 2024 Feb
26;62(3):373-84.
The authors have registered the study in Prospero. If yes, please provide the code.
Title: The Serum Hepcidin and the Hepcidin/Ferritin ratio in NAFLD: A Systematic Review
and Meta-Analysis
Version: 3 Date: 06 Dec 2024
Reviewer's report:
The Serum Hepcidin and the Hepcidin/Ferritin ratio in NAFLD: A Systematic Review and Meta-
Analysis
Abstract:
The introduction is long and confusing. Use up-to-date statistics.
Introduction
The gap of knowledge is not well mentioned.
There are many typographical and grammatical errors. The entire text needs to be rewritten. For
example, conducted by the PRISA guideline........ probably means PRISMA.
To structure the eligibility criteria, the PEO...??or PICO
Methods:
I expect the discussion to begin with the key findings of the study.
It is necessary to provide a publication bias funnel plot.
The authors justify the difference between their study and that of Sharma R, Zhao W, Zafar
Y, Murali AR, Brown KE. Serum hepcidin levels in chronic liver disease: a systematic
review and meta-analysis. Clinical Chemistry and Laboratory Medicine (CCLM). 2024 Feb
26;62(3):373-84.
The authors have registered the study in Prospero. If yes, please provide the code.
Please review this paper.
user
Title: The Serum Hepcidin and the Hepcidin/Ferritin ratio in NAFLD: A Systematic Review
and Meta-Analysis
Version: 3 Date: 06 Dec 2024
Reviewer's report:
The Serum Hepcidin and the Hepcidin/Ferritin ratio in NAFLD: A Systematic Review and Meta-
Analysis
Abstract:
The introduction is long and confusing. Use up-to-date statistics.
Introduction
The gap of knowledge is not well mentioned.
There are many typographical and grammatical errors. The entire text needs to be rewritten. For
example, conducted by the PRISA guideline........ probably means PRISMA.
To structure the eligibility criteria, the PEO...??or PICO
Methods:
I expect the discussion to begin with the key findings of the study.
It is necessary to provide a publication bias funnel plot.
The authors justify the difference between their study and that of Sharma R, Zhao W, Zafar
Y, Murali AR, Brown KE. Serum hepcidin levels in chronic liver disease: a systematic
review and meta-analysis. Clinical Chemistry and Laboratory Medicine (CCLM). 2024 Feb
26;62(3):373-84.
The authors have registered the study in Prospero. If yes, please provide the code.
assistant